A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Etravirine D4 | CAS 1142095-93-9 - Request Quote

Picture of Etravirine D4

Etravirine D4

SZ CAT No:SZ-E038D01
CAS No
1142095-93-9
Mol.F.
C20H11D4BrN6O
Mol.Wt.
439.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Etravirine D4 is chemically 4-((4-Amino-5-bromo-6-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)benzonitrile-2,3,5,6-d4. Etravirine D4 is supplied with detailed characterization data compliant with regulatory guideline. Etravirine D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Etravirine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1142095-93-9

Purchase 1142095-93-9

Order 1142095-93-9

Enquire 1142095-93-9

price of 1142095-93-9

1142095-93-9 Supplier

1142095-93-9 Manufacturer

1142095-93-9 Exporter

buy high quality Etravirine D4

Purchase Etravirine D4

Etravirine D4 suppliers

Etravirine D4 manufacturers

Etravirine D4 price

Order Etravirine D4

Enquire Etravirine D4

Etravirine D4 cost

Etravirine D4 Supplier

Etravirine D4 Distributor

Etravirine D4 for Method Validation

Etravirine Reference Standard

Etravirine D4 for ANDA Filing

Etravirine D4 for Forced Degradation Studies

Etravirine D4 Identification Standards

Etravirine D4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,